Imugene Ltd (ASX:IMU, OTC:IUGNF) CEO Leslie Chong speaks with Proactive soon after positive new data regarding overall survival results in its HER-Vaxx HERIZON study was provided in an oral presentation at the ESMO Asia Congress 2022 in Singapore. Chong also discusses upcoming conferences and investor presentations including the JP Morgan Healthcare Conference 2023 in January in which Imugene has been invited to attend and speak.
Imugene presents positive new data at key congress
